Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Insight into Drug Resistance in Metastatic Melanoma

Published: Wednesday, June 04, 2014
Last Updated: Wednesday, June 04, 2014
Bookmark and Share
A study by scientists in Manchester has shown how melanoma drugs can cause the cancer to progress once a patient has stopped responding to treatment.

Their findings suggest that using a combination of targeted therapies may be a more effective approach in the clinic. 

Melanoma is a form of cancer that develops from melanocytes – the pigment-producing cells in skin. Advanced metastatic melanoma – where the cancer has spread throughout the body – is associated with poor survival, so new treatments are urgently needed. 

In about 50% of melanoma cases, the tumour contains a mutation in a gene known as BRAF. Drugs that target BRAF – such as vemurafenib – have increased survival in patients with this mutation. However, many of these patients go on to develop resistance to treatment and their disease returns.

Now researchers from the Cancer Research UK Manchester Institute at The University of Manchester – part of the Manchester Cancer Research Centre – have explored what happens in melanoma cells following inhibition of BRAF.

Professor Richard Marais, who led the research, said: “BRAF inhibitors have improved survival for patients with metastatic melanoma. Unfortunately, eventual drug resistance is preventing long-term cure in most of these patients. We wanted to understand how these drugs might induce unwanted effects in melanoma cells – particularly in cells which also have a mutation in the RAS gene.”

The group found that blocking BRAF activity, either using drugs or by altering a cell’s genes, led to the RAS-mutated melanoma cells changing shape and becoming more invasive. These changes in behaviour would lead to metastatic spread of the disease throughout the body. Their study, published recently in the journal Science Signaling, showed that the BRAF inhibitors re-activated certain pathways within cells leading to melanoma cells becoming resistant to therapy.

“We found that we could counteract this behaviour by adding a second drug to the BRAF inhibitor – one that targets MEK. It looks like our study further supports the combined use of both BRAF and MEK inhibitors in melanoma patients,” added Professor Marais.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Molecular Clues to Serious Illnesses to be Explored
The University of Manchester is to lead a new £2.9 million molecular pathology research project to improve diagnosis and treatment of non-cancerous diseases within the NHS.
Tuesday, July 28, 2015
Mould Unlocks New Route to Biofuels
Scientists at The University of Manchester have made an important discovery that forms the basis for the development of new applications in biofuels and the sustainable manufacturing of chemicals.
Monday, July 06, 2015
Gene Variants Show Potential In Predicting Rheumatoid Arthritis Disease Outcomes
Arthritis Research UK-funded scientists at The University of Manchester have identified a new way in which genotyping can be used to predict disease outcomes among sufferers of rheumatoid arthritis.
Thursday, April 30, 2015
Potential For Prediction Of Progression For Early Form Of Breast Cancer
Scientists in Manchester have identified a way to potentially predict which patients with an early form of breast cancer will experience disease progression.
Friday, April 17, 2015
Surprising Finding In Stroke Research
Scientists at The University of Manchester have made an important new discovery about the brain’s immune system that could lead to potential new treatments for stroke and other related conditions.
Wednesday, March 18, 2015
Current Detection of Gene Mutations Misses People At High Risk Of Cancer
Research on the BRCA gene mutation in the Jewish population shows that the current process of identifying people misses half the people who have the mutation and are at risk of developing cancer.
Tuesday, December 02, 2014
‘Liquid Biopsy’ Offers New Way to Track Lung Cancer
Scientists have shown how a lung cancer patient’s blood sample could be used to monitor and predict their response to treatment.
Wednesday, June 04, 2014
Health Risks from Arsenic in Rice Exposed
High levels of arsenic in rice have been shown to be associated with elevated genetic damage in humans, a new study has found.
Wednesday, July 24, 2013
Study Maps Human Metabolism in Health and Disease
Scientists have produced an instruction manual for the human genome that provides a framework to better understand the relationship between an individual’s genetic make-up and their lifestyle.
Monday, March 04, 2013
Yeast Unravels Effects of Chemotherapy Drugs
Researchers identify new biological processes involved in the cellular response to N-BPs, opening up opportunities for the development of new anticancer drugs.
Friday, September 11, 2009
New Strategy in Fight against Cancer
Scientists have identified a new strategy in the fight against cancer, having found a mechanism for switching off a chemical signal that is intimately linked to progression of the disease.
Monday, September 22, 2008
Gene may Hold Key to Future Cancer Hope
The University of Manchester research has identified a key gene that appears to play a critical role in the normal process of cell division.
Tuesday, October 09, 2007
Eden Biodesign and the University of Manchester Intellectual Property Limited Develop Innovative Treatment for Cancer
UMIP selects Eden Biodesign to provide a range of services for the development of therapeutic for treatment of macular degeneration and cancer.
Wednesday, August 08, 2007
£2million Dwarfism Study Launched
An international team of researchers have been awarded more than £2million to study the genetic causes of dwarfism in a bid to develop future treatments.
Friday, June 01, 2007
Stem Cells Provide Clues to Cancer Spread
University of Manchester scientists have made a discovery in understanding how cancers spread in what could lead to new ways of beating the disease.
Thursday, May 24, 2007
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Diagnostic Test Developed for Enterovirus D68
researchers at Washington University School of Medicine in St. Louis have developed a diagnostic test to quickly detect enterovirus D68 (EV-D68), a respiratory virus that caused unusually severe illness in children last year.
How a Kernel Got Naked and Corn Became King
Ten thousand years ago, a golden grain got naked, brought people together and grew to become one of the top agricultural commodities on the planet.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!